Objective To report the design and implementation of the Right Drug, Right Dose, Right
Time—Using Genomic Data to Individualize Treatment protocol that was developed to test the …

Purpose The Mayo-Baylor RIGHT 10K Study enabled preemptive, sequence-based
pharmacogenomics (PGx)-driven drug prescribing practices in routine clinical care within a large …

The concept of optimizing health care by understanding and generating knowledge from
previous evidence, ie, the Learning Health-care System (LHS), has gained momentum and now …

OBJECTIVE To create a cohort for cost-effective genetic research, the Mayo Genome
Consortia (MayoGC) has been assembled with participants from research studies across Mayo …

The presence of personally identifiable information (PII) in natural language portions of
electronic health records (EHRs) constrains their broad reuse. Despite continuous improvements …

Genetic modulation of drug response can cause lifethreatening adverse drug reactions,
increase susceptibility to drug–drug interactions and alter therapeutic effectiveness. 1–3 …

Ageing of the immune system is characterized by decreased lymphopoiesis and adaptive
immunity, and increased inflammation and myeloid pathologies 1, 2. Age-related changes in …

Ferroportin is the primary means of cellular iron efflux and a key component of iron metabolism.
Hepcidin regulates Fpn activity by inducing its internalization and degradation. The …

Recent studies have found that natural resources and civil war are highly correlated. Yet the
causal mechanisms behind the correlation are not well understood, in part because data on …

Semiconductor heterostructures are backbones for solid-state-based optoelectronic devices.
Recent advances in assembly techniques for van der Waals heterostructures have enabled …